Molecular Imaging in Oncology: the Acceptance of PET/CT and the Emergence of MR/PET Imaging

Overview

Journal Eur Radiol

Specialty Radiology

Date 2010 Dec 22

PMID 21174096

Citations 13

Authors

Christiaan Schiepers

Magnus Dahlbom

Affiliations

Soon will be listed here.

Abstract

In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinical practice. Currently, PET-CT is a major diagnostic tool in oncology. At the dawn of the merger of MRI and PET, another breakthrough in clinical imaging is expected. The combination of these imaging modalities is challenging, but has particular features such as imaging biological processes at the same time in specific body locations.

Citing Articles

Quantitative and qualitative evaluation of sequential PET/MRI using a newly developed mobile PET system for brain imaging.

Suzuki M, Fushimi Y, Okada T, Hinoda T, Nakamoto R, Arakawa Y Jpn J Radiol. 2021; 39(7):669-680.

PMID: 33641056 DOI: 10.1007/s11604-021-01105-9.

Very Early Response Evaluation by PET/MR in Patients with Lung Cancer-Timing and Feasibility.

Langer N, Langer S, Johannesen H, Hansen A, Costa J, Klausen T Diagnostics (Basel). 2019; 9(1).

PMID: 30917539 PMC: 6468790. DOI: 10.3390/diagnostics9010035.

Diagnostic Performance of Whole-Body PET/MRI for Detecting Malignancies in Cancer Patients: A Meta-Analysis.

Shen G, Hu S, Liu B, Kuang A PLoS One. 2016; 11(4):e0154497.

PMID: 27124545 PMC: 4849712. DOI: 10.1371/journal.pone.0154497.

A new assessment model for tumor heterogeneity analysis with [18]F-FDG PET images.

Wang P, Xu W, Sun J, Yang C, Wang G, Sa Y EXCLI J. 2016; 15:75-84.

PMID: 27065775 PMC: 4822048. DOI: 10.17179/excli2015-723.

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems.

Oprea-Lager D, Yaqub M, Pieters I, Reinhard R, van Moorselaar R, van den Eertwegh A Mol Imaging Biol. 2015; 17(5):714-25.

PMID: 25690949 PMC: 4768240. DOI: 10.1007/s11307-015-0826-8.

References

Lakkaraju A, Patel C, Bradley K, Scarsbrook A . PET/CT in primary musculoskeletal tumours: a step forward. Eur Radiol. 2010; 20(12):2959-72. DOI: 10.1007/s00330-010-1862-z. View

Veit-Haibach P, Antoch G, Beyer T, Stergar H, Schleucher R, Hauth E . FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol. 2007; 80(955):508-15. DOI: 10.1259/bjr/17395663. View

Kumar A, Kumar R, Seenu V, Gupta S, Chawla M, Malhotra A . The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol. 2009; 19(6):1347-57. DOI: 10.1007/s00330-009-1303-z. View

Gambhir S, Czernin J, SCHWIMMER J, Silverman D, Coleman R, Phelps M . A tabulated summary of the FDG PET literature. J Nucl Med. 2001; 42(5 Suppl):1S-93S. View

Freudenberg L, Rosenbaum S, Beyer T, Bockisch A, Antoch G . PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Thorac Surg Clin. 2010; 20(1):25-30. DOI: 10.1016/j.thorsurg.2009.12.003. View

Goerres G, Michel S, Fehr M, Kaim A, Steinert H, Seifert B . Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol. 2003; 13(7):1635-44. DOI: 10.1007/s00330-002-1720-8. View

Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L, Israel O . The role of FDG-PET/CT in suspected recurrence of breast cancer. Cancer. 2006; 107(11):2545-51. DOI: 10.1002/cncr.22292. View

Prakash P, Cronin C, Blake M . Role of PET/CT in ovarian cancer. AJR Am J Roentgenol. 2010; 194(6):W464-70. DOI: 10.2214/AJR.09.3843. View

Kamel E, Burger C, Buck A, von Schulthess G, Goerres G . Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol. 2003; 13(4):724-8. DOI: 10.1007/s00330-002-1564-2. View

10.

Yoon D, Hwang H, Chang S, Rho Y, Ahn H, Kim J . CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol. 2008; 19(3):634-42. DOI: 10.1007/s00330-008-1192-6. View

11.

Podoloff D, Macapinlac H . PET and PET/CT in management of the lymphomas. Radiol Clin North Am. 2007; 45(4):689-96, vii. DOI: 10.1016/j.rcl.2007.05.008. View

12.

Patil V, Wang Z, Sollitto R, Chuang K, Konety B, Hawkins R . 18F-FDG PET/CT of transitional cell carcinoma. AJR Am J Roentgenol. 2009; 193(6):W497-504. DOI: 10.2214/AJR.08.1945. View

13.

Hofman M, Smeeton N, Rankin S, Nunan T, ODoherty M . Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging. J Nucl Med. 2009; 50(10):1594-7. DOI: 10.2967/jnumed.109.064121. View

14.

Ell P . The contribution of PET/CT to improved patient management. Br J Radiol. 2006; 79(937):32-6. DOI: 10.1259/bjr/18454286. View

15.

Fueger B, Weber W, Quon A, Crawford T, Allen-Auerbach M, Halpern B . Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol. 2005; 7(5):369-76. DOI: 10.1007/s11307-005-0013-4. View

16.

Rosenbaum S, Lind T, Antoch G, Bockisch A . False-positive FDG PET uptake--the role of PET/CT. Eur Radiol. 2005; 16(5):1054-65. DOI: 10.1007/s00330-005-0088-y. View

17.

Goerres G, Burger C, Schwitter M, Heidelberg T, Seifert B, von Schulthess G . PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol. 2003; 13(4):734-9. DOI: 10.1007/s00330-002-1548-2. View

18.

Kidd E, Siegel B, Dehdashti F, Rader J, Mutch D, Powell M . Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010; 28(12):2108-13. DOI: 10.1200/JCO.2009.25.4151. View

19.

Schmidt G, Haug A, Schoenberg S, Reiser M . Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol. 2006; 16(6):1216-25. DOI: 10.1007/s00330-006-0183-8. View

20.

Adams M, Turkington T, Wilson J, Wong T . A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010; 195(2):310-20. DOI: 10.2214/AJR.10.4923. View